Shreeyashi Ojha

London

Reporter at BioProcess International Magazine

Featured in: Favicon

bioprocessintl.com Favicon

canadanewsjournal.com Favicon

pv-tech.org

Articles

Intersolar Europe 2025: smarter E Award winners unveiled, Canadian Solar, Aiko Solar launch new modules

1 week ago | pv-tech.org | Shreeyashi Ojha

Intersolar Europe 2025, held this week in Munich, Germany, continues to be a major gathering in the solar industry, bringing together global attendees and showcasing a variety of new products from PV companies. Solar manufacturers Aiko Solar and Canadian Solar showcased their latest modules, while 7Secondsolar, LONGi Solar and Weidmüller won in the Photovoltaics (PV) category at this year’s The smarter E Award.
Astraveus, NecstGen team up to tackle CGT bottlenecks

1 week ago | bioprocessintl.com | Shreeyashi Ojha

The Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen) will assess Paris-based firm Astraveus’ Lakhesys benchtop cell factory, which is a chimeric antigen receptor (CAR)-T therapy manufacturing technology. As per the agreement, the partnership aims to use the cell factory to cut costs and increase efficacy in CAR-T production. Additionally, NecstGen will manufacture lentiviral vectors (LVVs) for R&D.
US ROUND-UP: EDPR NA, DESRI grid-scale solar projects, Microsoft backs Nexamp’s 300MW clean energy rollout

1 week ago | pv-tech.org | Shreeyashi Ojha

In a week of notable updates from the US clean energy market, DESRI and EDPR NA kicked off construction of solar farms in Michigan and California respectively, while Nexamp partnered with Microsoft to develop around 100 distributed solar projects across the country. Houston, Texas headquartered EDP Renewables North America (EDPR NA) has opened its 200MW Scarlet II Solar Energy Park in Fresno County, California.
Cypress Creek Renewables closes US$150 million financing for 104MW Washington solar project

1 week ago | pv-tech.org | Shreeyashi Ojha

Independent power producer (IPP) Cypress Creek Renewables has secured US$150 million in financing to advance the construction of its 104MW Ostrea Solar project in northeast Yakima County, Washington. The financing round was led by MUFG Bank, with participation from BNP Paribas, DNB Bank ASA, and Santander. This article requires Premium SubscriptionBasic (FREE) SubscriptionUnlock unlimited access for 12 whole months of distinctive global analysisPhotovoltaics International is now included.
Biopharma players shuffle c-suite ranks

2 weeks ago | bioprocessintl.com | Shreeyashi Ojha

The biotechnology company specializing in chimeric antigen receptor (CAR-Ts) has announced that Paul Stoffels will step down as its CEO while he continues as the non-executive chair of the board of directors. The board expects to appoint Stoffels’ successor within the next 12 months to lead the company into its next phase of growth and innovation as a focused cell therapy company.
Sunraycer, Meta sign 310MW solar PV EAPA in Texas

2 weeks ago | pv-tech.org | Shreeyashi Ojha

Solar developer Sunraycer Renewables has signed two Environmental Attribute Purchase Agreements (EAPAs) with data and technology bigwig Meta for 310MW of solar PV in Texas, US. The two projects, located in Hill County (Midpoint Solar) and Navarro County (Gaia Solar), will deliver 127MW and 184MW of energy, respectively, to the Electric Reliability Council of Texas (ERCOT) grid.
Alliant Energy commissions solar capacity with 200MW Iowa plant

2 weeks ago | pv-tech.org | Shreeyashi Ojha

US utility Alliant Energy has opened a 200MW solar facility in Linn County, Iowa. The project was developed by Duane Arnold Solar, a NextEra Energy Resources subsidiary, in two phases. The first phase began operations in March 2025 while the remaining 150MW opened in December 2024. This article requires Premium SubscriptionBasic (FREE) SubscriptionUnlock unlimited access for 12 whole months of distinctive global analysisPhotovoltaics International is now included.
Thermo Fisher reports Q1 growth, charts a steady course for 2025

2 weeks ago | bioprocessintl.com | Shreeyashi Ojha

For the first quarter of 2025, Thermo Fisher Scientific reported revenue of $10.36 billion, with an adjusted operating income of $2.27 billion. The adjusted operating margin for the quarter stood at 21.9%. Marc Casper, CEO of Thermo Fisher, said pharma and biotech had a modest growth, driven by bioproduction and services, amid macroeconomic uncertainty and shifting policies. For 2025, the company aims to strengthen its US manufacturing and ramp up R&D investment.
Merck & Co. bolsters Keytruda production with $1bn US plant

2 weeks ago | bioprocessintl.com | Shreeyashi Ojha

The 470,000 square-foot facility will house laboratory, manufacturing, and warehouse capabilities to support the commercial production of Keytruda and other biologics and therapies, including antibody drug conjugates (ADCs). The facility is expected to employ over 500 people and open by 2028, with production of investigational compounds anticipated to begin by 2030.
PCI bolsters fill/finish capacity with Althea buy

2 weeks ago | bioprocessintl.com | Shreeyashi Ojha

PCI Pharma has acquired aseptic fill/finish contract development and manufacturing organization (CDMO) Althea, a subsidiary of Japan-based Ajinomoto. The San Diego plant consists of seven buildings on three sites and is located close to PCI’s existing clinical trial and manufacturing facilities. The facilities produce prefilled syringes, cartridges, and high potent formulations such as antibody drug conjugates (ADCs). The financials of this transaction were not disclosed.